経皮モニタリング(TCM)システムの世界市場成長 2024-2030Global Transcutaneous Monitoring(TCM) System Market Growth 2024-2030 LPI(LPインフォメーション)の最新調査によると、世界の経皮モニタ(TCM)システム市場規模は2023年に100万米ドルと評価されました。下流市場での需要拡大に伴い、経皮モニタリング(TCM)システムは、レビュー... もっと見る
サマリーLPI(LPインフォメーション)の最新調査によると、世界の経皮モニタ(TCM)システム市場規模は2023年に100万米ドルと評価されました。下流市場での需要拡大に伴い、経皮モニタリング(TCM)システムは、レビュー期間中のCAGR %で、2030年までに百万米ドルの再調整規模になると予測されています。この調査レポートは、世界の経皮モニタリング(TCM)システム市場の成長可能性を明らかにしています。経皮モニタリング(TCM)システムは今後の市場でも安定した成長が期待される。しかし、経皮モニタリング(TCM)システムの普及には、製品の差別化、コスト削減、サプライチェーンの最適化が引き続き重要である。市場関係者は、経皮モニタリング(TCM)システム市場が提供する膨大な機会を活用するために、研究開発に投資し、戦略的パートナーシップを築き、進化する消費者の嗜好に合わせた製品を提供する必要がある。 経皮モニタ(TCM)は、最小限の採血で酸素と二酸化炭素の継続的なモニタリングを必要とする患者のための非侵襲的な方法である。経皮モニタ(TCM)は、非侵襲的な技術を用いて皮膚表面の二酸化炭素分圧(PtcCO2)と酸素分圧(PtcO2)を測定し、動脈内の二酸化炭素分圧(PaCO2)と酸素分圧(PaO2)の推定値を提供する。 主な特徴 経皮モニタリング(TCM)システム市場に関するレポートは様々な側面を反映し、業界に関する貴重な洞察を提供します。 市場規模と成長:この調査レポートは、経皮モニタリング(TCM)システム市場の現在の規模と成長の概要を提供しています。過去データ、タイプ別市場区分(例:ポータブルタイプ、固定タイプ)、地域別内訳などが含まれます。 市場促進要因と課題:経皮モニタ(TCM)システム市場の成長を促進する要因(政府規制、環境問題、技術進歩、消費者嗜好の変化など)を特定・分析することができます。また、インフラストラクチャーの制限、射程距離への不安、初期コストの高さなど、業界が直面する課題も浮き彫りにすることができる。 競合情勢:この調査レポートは、経皮モニタリング(TCM)システム市場内の競合状況の分析を提供しています。主要企業のプロフィール、市場シェア、戦略、製品提供などが含まれる。また、新興企業や市場に与える潜在的な影響にもスポットを当てています。 技術開発:調査レポートは、経皮モニタリング(TCM)システム産業における最新の技術開発を掘り下げることができます。これには、経皮モニタリング(TCM)システム技術の進歩、経皮モニタリング(TCM)システムの新規参入、経皮モニタリング(TCM)システムの新規投資、経皮モニタリング(TCM)システムの将来を形作るその他の技術革新が含まれます。 川下の事業者選好:本レポートは、経皮モニタ(TCM)システム市場における顧客の購買行動と採用動向を明らかにすることができます。顧客の購買決定や経皮モニタ(TCM)システム製品の嗜好に影響を与える要因も含まれています。 政府の政策とインセンティブこの調査レポートは、経皮モニタ(TCM)システム市場に対する政府の政策とインセンティブの影響を分析しています。これには、規制の枠組み、補助金、税制優遇措置、経皮モニタ(TCM)システム市場の促進を目的としたその他の措置の評価が含まれる。また、市場成長促進におけるこれらの政策の有効性についても評価しています。 環境への影響と持続可能性経皮モニタリング(TCM)システム市場の環境への影響と持続可能性の側面を評価します。 市場予測と将来展望:当調査レポートでは、実施した分析に基づいて、経皮モニタリング(TCM)システム産業の市場予測と展望を提供しています。これには、市場規模、成長率、地域動向、技術進歩や政策展開に関する予測などが含まれます。 提言と機会本レポートは、業界関係者、政策立案者、投資家への提言で締めくくられています。市場関係者が新たなトレンドを活用し、課題を克服し、経皮モニタリング(TCM)システム市場の成長と発展に貢献するための潜在的な機会を強調しています。 市場の細分化 経皮モニタリング(TCM)システム市場は、タイプ別と用途別に分割される。2019-2030年の期間について、セグメント間の成長により、タイプ別、用途別の消費額の正確な計算と予測を数量と金額で提供します。 タイプ別セグメント ポータブルタイプ 固定タイプ 用途別セグメント 新生児集中治療室 成人集中治療室 その他 本レポートは地域別にも市場を分割しています: 南北アメリカ アメリカ カナダ メキシコ ブラジル APAC 中国 日本 韓国 東南アジア インド オーストラリア ヨーロッパ ドイツ フランス 英国 イタリア ロシア 中東・アフリカ エジプト 南アフリカ イスラエル トルコ GCC諸国 以下の企業は、主要な専門家から収集した情報、および企業のカバレッジ、製品ポートフォリオ、市場浸透度の分析に基づいて選択されています。 A. デモリ センテック ラジオメーター プライムドAB フィリップス バイオクリニカルサービス コンピュメディックス社 ドロットメディジンテクニック ペリメッド 本レポートで扱う主な質問 世界の経皮モニタリング(TCM)システム市場の10年展望は? 経皮モニタリング(TCM)システムの世界市場および地域別市場成長の要因は何か? 市場別、地域別で最も急成長する技術は何か? 経皮モニタ(TCM)システムの市場機会は最終市場規模によってどのように異なるのか? 経皮モニタ(TCM)システムのタイプ別、用途別内訳は? 目次1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Transcutaneous Monitoring(TCM) System Annual Sales 2019-2030 2.1.2 World Current & Future Analysis for Transcutaneous Monitoring(TCM) System by Geographic Region, 2019, 2023 & 2030 2.1.3 World Current & Future Analysis for Transcutaneous Monitoring(TCM) System by Country/Region, 2019, 2023 & 2030 2.2 Transcutaneous Monitoring(TCM) System Segment by Type 2.2.1 Portable Type 2.2.2 Fixed Type 2.3 Transcutaneous Monitoring(TCM) System Sales by Type 2.3.1 Global Transcutaneous Monitoring(TCM) System Sales Market Share by Type (2019-2024) 2.3.2 Global Transcutaneous Monitoring(TCM) System Revenue and Market Share by Type (2019-2024) 2.3.3 Global Transcutaneous Monitoring(TCM) System Sale Price by Type (2019-2024) 2.4 Transcutaneous Monitoring(TCM) System Segment by Application 2.4.1 Neonatal Intensive Care Unit 2.4.2 Adult Intensive Care Unit 2.4.3 Others 2.5 Transcutaneous Monitoring(TCM) System Sales by Application 2.5.1 Global Transcutaneous Monitoring(TCM) System Sale Market Share by Application (2019-2024) 2.5.2 Global Transcutaneous Monitoring(TCM) System Revenue and Market Share by Application (2019-2024) 2.5.3 Global Transcutaneous Monitoring(TCM) System Sale Price by Application (2019-2024) 3 Global Transcutaneous Monitoring(TCM) System by Company 3.1 Global Transcutaneous Monitoring(TCM) System Breakdown Data by Company 3.1.1 Global Transcutaneous Monitoring(TCM) System Annual Sales by Company (2019-2024) 3.1.2 Global Transcutaneous Monitoring(TCM) System Sales Market Share by Company (2019-2024) 3.2 Global Transcutaneous Monitoring(TCM) System Annual Revenue by Company (2019-2024) 3.2.1 Global Transcutaneous Monitoring(TCM) System Revenue by Company (2019-2024) 3.2.2 Global Transcutaneous Monitoring(TCM) System Revenue Market Share by Company (2019-2024) 3.3 Global Transcutaneous Monitoring(TCM) System Sale Price by Company 3.4 Key Manufacturers Transcutaneous Monitoring(TCM) System Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Transcutaneous Monitoring(TCM) System Product Location Distribution 3.4.2 Players Transcutaneous Monitoring(TCM) System Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Transcutaneous Monitoring(TCM) System by Geographic Region 4.1 World Historic Transcutaneous Monitoring(TCM) System Market Size by Geographic Region (2019-2024) 4.1.1 Global Transcutaneous Monitoring(TCM) System Annual Sales by Geographic Region (2019-2024) 4.1.2 Global Transcutaneous Monitoring(TCM) System Annual Revenue by Geographic Region (2019-2024) 4.2 World Historic Transcutaneous Monitoring(TCM) System Market Size by Country/Region (2019-2024) 4.2.1 Global Transcutaneous Monitoring(TCM) System Annual Sales by Country/Region (2019-2024) 4.2.2 Global Transcutaneous Monitoring(TCM) System Annual Revenue by Country/Region (2019-2024) 4.3 Americas Transcutaneous Monitoring(TCM) System Sales Growth 4.4 APAC Transcutaneous Monitoring(TCM) System Sales Growth 4.5 Europe Transcutaneous Monitoring(TCM) System Sales Growth 4.6 Middle East & Africa Transcutaneous Monitoring(TCM) System Sales Growth 5 Americas 5.1 Americas Transcutaneous Monitoring(TCM) System Sales by Country 5.1.1 Americas Transcutaneous Monitoring(TCM) System Sales by Country (2019-2024) 5.1.2 Americas Transcutaneous Monitoring(TCM) System Revenue by Country (2019-2024) 5.2 Americas Transcutaneous Monitoring(TCM) System Sales by Type 5.3 Americas Transcutaneous Monitoring(TCM) System Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Transcutaneous Monitoring(TCM) System Sales by Region 6.1.1 APAC Transcutaneous Monitoring(TCM) System Sales by Region (2019-2024) 6.1.2 APAC Transcutaneous Monitoring(TCM) System Revenue by Region (2019-2024) 6.2 APAC Transcutaneous Monitoring(TCM) System Sales by Type 6.3 APAC Transcutaneous Monitoring(TCM) System Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Transcutaneous Monitoring(TCM) System by Country 7.1.1 Europe Transcutaneous Monitoring(TCM) System Sales by Country (2019-2024) 7.1.2 Europe Transcutaneous Monitoring(TCM) System Revenue by Country (2019-2024) 7.2 Europe Transcutaneous Monitoring(TCM) System Sales by Type 7.3 Europe Transcutaneous Monitoring(TCM) System Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Transcutaneous Monitoring(TCM) System by Country 8.1.1 Middle East & Africa Transcutaneous Monitoring(TCM) System Sales by Country (2019-2024) 8.1.2 Middle East & Africa Transcutaneous Monitoring(TCM) System Revenue by Country (2019-2024) 8.2 Middle East & Africa Transcutaneous Monitoring(TCM) System Sales by Type 8.3 Middle East & Africa Transcutaneous Monitoring(TCM) System Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Transcutaneous Monitoring(TCM) System 10.3 Manufacturing Process Analysis of Transcutaneous Monitoring(TCM) System 10.4 Industry Chain Structure of Transcutaneous Monitoring(TCM) System 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Transcutaneous Monitoring(TCM) System Distributors 11.3 Transcutaneous Monitoring(TCM) System Customer 12 World Forecast Review for Transcutaneous Monitoring(TCM) System by Geographic Region 12.1 Global Transcutaneous Monitoring(TCM) System Market Size Forecast by Region 12.1.1 Global Transcutaneous Monitoring(TCM) System Forecast by Region (2025-2030) 12.1.2 Global Transcutaneous Monitoring(TCM) System Annual Revenue Forecast by Region (2025-2030) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Transcutaneous Monitoring(TCM) System Forecast by Type 12.7 Global Transcutaneous Monitoring(TCM) System Forecast by Application 13 Key Players Analysis 13.1 A. De Mori 13.1.1 A. De Mori Company Information 13.1.2 A. De Mori Transcutaneous Monitoring(TCM) System Product Portfolios and Specifications 13.1.3 A. De Mori Transcutaneous Monitoring(TCM) System Sales, Revenue, Price and Gross Margin (2019-2024) 13.1.4 A. De Mori Main Business Overview 13.1.5 A. De Mori Latest Developments 13.2 Sentec 13.2.1 Sentec Company Information 13.2.2 Sentec Transcutaneous Monitoring(TCM) System Product Portfolios and Specifications 13.2.3 Sentec Transcutaneous Monitoring(TCM) System Sales, Revenue, Price and Gross Margin (2019-2024) 13.2.4 Sentec Main Business Overview 13.2.5 Sentec Latest Developments 13.3 Radiometer 13.3.1 Radiometer Company Information 13.3.2 Radiometer Transcutaneous Monitoring(TCM) System Product Portfolios and Specifications 13.3.3 Radiometer Transcutaneous Monitoring(TCM) System Sales, Revenue, Price and Gross Margin (2019-2024) 13.3.4 Radiometer Main Business Overview 13.3.5 Radiometer Latest Developments 13.4 Primed AB 13.4.1 Primed AB Company Information 13.4.2 Primed AB Transcutaneous Monitoring(TCM) System Product Portfolios and Specifications 13.4.3 Primed AB Transcutaneous Monitoring(TCM) System Sales, Revenue, Price and Gross Margin (2019-2024) 13.4.4 Primed AB Main Business Overview 13.4.5 Primed AB Latest Developments 13.5 Philips 13.5.1 Philips Company Information 13.5.2 Philips Transcutaneous Monitoring(TCM) System Product Portfolios and Specifications 13.5.3 Philips Transcutaneous Monitoring(TCM) System Sales, Revenue, Price and Gross Margin (2019-2024) 13.5.4 Philips Main Business Overview 13.5.5 Philips Latest Developments 13.6 Bioclinical Services 13.6.1 Bioclinical Services Company Information 13.6.2 Bioclinical Services Transcutaneous Monitoring(TCM) System Product Portfolios and Specifications 13.6.3 Bioclinical Services Transcutaneous Monitoring(TCM) System Sales, Revenue, Price and Gross Margin (2019-2024) 13.6.4 Bioclinical Services Main Business Overview 13.6.5 Bioclinical Services Latest Developments 13.7 Compumedics Limited 13.7.1 Compumedics Limited Company Information 13.7.2 Compumedics Limited Transcutaneous Monitoring(TCM) System Product Portfolios and Specifications 13.7.3 Compumedics Limited Transcutaneous Monitoring(TCM) System Sales, Revenue, Price and Gross Margin (2019-2024) 13.7.4 Compumedics Limited Main Business Overview 13.7.5 Compumedics Limited Latest Developments 13.8 Drott Medizintechnik 13.8.1 Drott Medizintechnik Company Information 13.8.2 Drott Medizintechnik Transcutaneous Monitoring(TCM) System Product Portfolios and Specifications 13.8.3 Drott Medizintechnik Transcutaneous Monitoring(TCM) System Sales, Revenue, Price and Gross Margin (2019-2024) 13.8.4 Drott Medizintechnik Main Business Overview 13.8.5 Drott Medizintechnik Latest Developments 13.9 Perimed 13.9.1 Perimed Company Information 13.9.2 Perimed Transcutaneous Monitoring(TCM) System Product Portfolios and Specifications 13.9.3 Perimed Transcutaneous Monitoring(TCM) System Sales, Revenue, Price and Gross Margin (2019-2024) 13.9.4 Perimed Main Business Overview 13.9.5 Perimed Latest Developments 14 Research Findings and Conclusion
SummaryAccording to our LPI (LP Information) latest study, the global Transcutaneous Monitoring(TCM) System market size was valued at US$ million in 2023. With growing demand in downstream market, the Transcutaneous Monitoring(TCM) System is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. Table of Contents1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Transcutaneous Monitoring(TCM) System Annual Sales 2019-2030 2.1.2 World Current & Future Analysis for Transcutaneous Monitoring(TCM) System by Geographic Region, 2019, 2023 & 2030 2.1.3 World Current & Future Analysis for Transcutaneous Monitoring(TCM) System by Country/Region, 2019, 2023 & 2030 2.2 Transcutaneous Monitoring(TCM) System Segment by Type 2.2.1 Portable Type 2.2.2 Fixed Type 2.3 Transcutaneous Monitoring(TCM) System Sales by Type 2.3.1 Global Transcutaneous Monitoring(TCM) System Sales Market Share by Type (2019-2024) 2.3.2 Global Transcutaneous Monitoring(TCM) System Revenue and Market Share by Type (2019-2024) 2.3.3 Global Transcutaneous Monitoring(TCM) System Sale Price by Type (2019-2024) 2.4 Transcutaneous Monitoring(TCM) System Segment by Application 2.4.1 Neonatal Intensive Care Unit 2.4.2 Adult Intensive Care Unit 2.4.3 Others 2.5 Transcutaneous Monitoring(TCM) System Sales by Application 2.5.1 Global Transcutaneous Monitoring(TCM) System Sale Market Share by Application (2019-2024) 2.5.2 Global Transcutaneous Monitoring(TCM) System Revenue and Market Share by Application (2019-2024) 2.5.3 Global Transcutaneous Monitoring(TCM) System Sale Price by Application (2019-2024) 3 Global Transcutaneous Monitoring(TCM) System by Company 3.1 Global Transcutaneous Monitoring(TCM) System Breakdown Data by Company 3.1.1 Global Transcutaneous Monitoring(TCM) System Annual Sales by Company (2019-2024) 3.1.2 Global Transcutaneous Monitoring(TCM) System Sales Market Share by Company (2019-2024) 3.2 Global Transcutaneous Monitoring(TCM) System Annual Revenue by Company (2019-2024) 3.2.1 Global Transcutaneous Monitoring(TCM) System Revenue by Company (2019-2024) 3.2.2 Global Transcutaneous Monitoring(TCM) System Revenue Market Share by Company (2019-2024) 3.3 Global Transcutaneous Monitoring(TCM) System Sale Price by Company 3.4 Key Manufacturers Transcutaneous Monitoring(TCM) System Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Transcutaneous Monitoring(TCM) System Product Location Distribution 3.4.2 Players Transcutaneous Monitoring(TCM) System Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Transcutaneous Monitoring(TCM) System by Geographic Region 4.1 World Historic Transcutaneous Monitoring(TCM) System Market Size by Geographic Region (2019-2024) 4.1.1 Global Transcutaneous Monitoring(TCM) System Annual Sales by Geographic Region (2019-2024) 4.1.2 Global Transcutaneous Monitoring(TCM) System Annual Revenue by Geographic Region (2019-2024) 4.2 World Historic Transcutaneous Monitoring(TCM) System Market Size by Country/Region (2019-2024) 4.2.1 Global Transcutaneous Monitoring(TCM) System Annual Sales by Country/Region (2019-2024) 4.2.2 Global Transcutaneous Monitoring(TCM) System Annual Revenue by Country/Region (2019-2024) 4.3 Americas Transcutaneous Monitoring(TCM) System Sales Growth 4.4 APAC Transcutaneous Monitoring(TCM) System Sales Growth 4.5 Europe Transcutaneous Monitoring(TCM) System Sales Growth 4.6 Middle East & Africa Transcutaneous Monitoring(TCM) System Sales Growth 5 Americas 5.1 Americas Transcutaneous Monitoring(TCM) System Sales by Country 5.1.1 Americas Transcutaneous Monitoring(TCM) System Sales by Country (2019-2024) 5.1.2 Americas Transcutaneous Monitoring(TCM) System Revenue by Country (2019-2024) 5.2 Americas Transcutaneous Monitoring(TCM) System Sales by Type 5.3 Americas Transcutaneous Monitoring(TCM) System Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Transcutaneous Monitoring(TCM) System Sales by Region 6.1.1 APAC Transcutaneous Monitoring(TCM) System Sales by Region (2019-2024) 6.1.2 APAC Transcutaneous Monitoring(TCM) System Revenue by Region (2019-2024) 6.2 APAC Transcutaneous Monitoring(TCM) System Sales by Type 6.3 APAC Transcutaneous Monitoring(TCM) System Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Transcutaneous Monitoring(TCM) System by Country 7.1.1 Europe Transcutaneous Monitoring(TCM) System Sales by Country (2019-2024) 7.1.2 Europe Transcutaneous Monitoring(TCM) System Revenue by Country (2019-2024) 7.2 Europe Transcutaneous Monitoring(TCM) System Sales by Type 7.3 Europe Transcutaneous Monitoring(TCM) System Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Transcutaneous Monitoring(TCM) System by Country 8.1.1 Middle East & Africa Transcutaneous Monitoring(TCM) System Sales by Country (2019-2024) 8.1.2 Middle East & Africa Transcutaneous Monitoring(TCM) System Revenue by Country (2019-2024) 8.2 Middle East & Africa Transcutaneous Monitoring(TCM) System Sales by Type 8.3 Middle East & Africa Transcutaneous Monitoring(TCM) System Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Transcutaneous Monitoring(TCM) System 10.3 Manufacturing Process Analysis of Transcutaneous Monitoring(TCM) System 10.4 Industry Chain Structure of Transcutaneous Monitoring(TCM) System 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Transcutaneous Monitoring(TCM) System Distributors 11.3 Transcutaneous Monitoring(TCM) System Customer 12 World Forecast Review for Transcutaneous Monitoring(TCM) System by Geographic Region 12.1 Global Transcutaneous Monitoring(TCM) System Market Size Forecast by Region 12.1.1 Global Transcutaneous Monitoring(TCM) System Forecast by Region (2025-2030) 12.1.2 Global Transcutaneous Monitoring(TCM) System Annual Revenue Forecast by Region (2025-2030) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Transcutaneous Monitoring(TCM) System Forecast by Type 12.7 Global Transcutaneous Monitoring(TCM) System Forecast by Application 13 Key Players Analysis 13.1 A. De Mori 13.1.1 A. De Mori Company Information 13.1.2 A. De Mori Transcutaneous Monitoring(TCM) System Product Portfolios and Specifications 13.1.3 A. De Mori Transcutaneous Monitoring(TCM) System Sales, Revenue, Price and Gross Margin (2019-2024) 13.1.4 A. De Mori Main Business Overview 13.1.5 A. De Mori Latest Developments 13.2 Sentec 13.2.1 Sentec Company Information 13.2.2 Sentec Transcutaneous Monitoring(TCM) System Product Portfolios and Specifications 13.2.3 Sentec Transcutaneous Monitoring(TCM) System Sales, Revenue, Price and Gross Margin (2019-2024) 13.2.4 Sentec Main Business Overview 13.2.5 Sentec Latest Developments 13.3 Radiometer 13.3.1 Radiometer Company Information 13.3.2 Radiometer Transcutaneous Monitoring(TCM) System Product Portfolios and Specifications 13.3.3 Radiometer Transcutaneous Monitoring(TCM) System Sales, Revenue, Price and Gross Margin (2019-2024) 13.3.4 Radiometer Main Business Overview 13.3.5 Radiometer Latest Developments 13.4 Primed AB 13.4.1 Primed AB Company Information 13.4.2 Primed AB Transcutaneous Monitoring(TCM) System Product Portfolios and Specifications 13.4.3 Primed AB Transcutaneous Monitoring(TCM) System Sales, Revenue, Price and Gross Margin (2019-2024) 13.4.4 Primed AB Main Business Overview 13.4.5 Primed AB Latest Developments 13.5 Philips 13.5.1 Philips Company Information 13.5.2 Philips Transcutaneous Monitoring(TCM) System Product Portfolios and Specifications 13.5.3 Philips Transcutaneous Monitoring(TCM) System Sales, Revenue, Price and Gross Margin (2019-2024) 13.5.4 Philips Main Business Overview 13.5.5 Philips Latest Developments 13.6 Bioclinical Services 13.6.1 Bioclinical Services Company Information 13.6.2 Bioclinical Services Transcutaneous Monitoring(TCM) System Product Portfolios and Specifications 13.6.3 Bioclinical Services Transcutaneous Monitoring(TCM) System Sales, Revenue, Price and Gross Margin (2019-2024) 13.6.4 Bioclinical Services Main Business Overview 13.6.5 Bioclinical Services Latest Developments 13.7 Compumedics Limited 13.7.1 Compumedics Limited Company Information 13.7.2 Compumedics Limited Transcutaneous Monitoring(TCM) System Product Portfolios and Specifications 13.7.3 Compumedics Limited Transcutaneous Monitoring(TCM) System Sales, Revenue, Price and Gross Margin (2019-2024) 13.7.4 Compumedics Limited Main Business Overview 13.7.5 Compumedics Limited Latest Developments 13.8 Drott Medizintechnik 13.8.1 Drott Medizintechnik Company Information 13.8.2 Drott Medizintechnik Transcutaneous Monitoring(TCM) System Product Portfolios and Specifications 13.8.3 Drott Medizintechnik Transcutaneous Monitoring(TCM) System Sales, Revenue, Price and Gross Margin (2019-2024) 13.8.4 Drott Medizintechnik Main Business Overview 13.8.5 Drott Medizintechnik Latest Developments 13.9 Perimed 13.9.1 Perimed Company Information 13.9.2 Perimed Transcutaneous Monitoring(TCM) System Product Portfolios and Specifications 13.9.3 Perimed Transcutaneous Monitoring(TCM) System Sales, Revenue, Price and Gross Margin (2019-2024) 13.9.4 Perimed Main Business Overview 13.9.5 Perimed Latest Developments 14 Research Findings and Conclusion
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
LP Information社の医療分野での最新刊レポート本レポートと同じKEY WORD()の最新刊レポート
よくあるご質問LP Information社はどのような調査会社ですか?LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/15 10:26 157.84 円 166.62 円 202.61 円 |